Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

2007 • 4,623 citations

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

2006 • 2,724 citations

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

2009 • 2,144 citations

Lifetime Risk for Development of Atrial Fibrillation

2004 • 1,969 citations

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

2006 • 1,924 citations

Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation

1999 • 1,655 citations

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

1987 • 1,213 citations

Atrial Fibrillation: A Major Contributor to Stroke in the Elderly

1987 • 1,005 citations

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

2009 • 1,001 citations

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

2008 • 858 citations

Atrial fibrillation management: a prospective survey in ESC Member Countries

2005 • 828 citations

Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation

2002 • 725 citations

Why Do Patients With Atrial Fibrillation Not Receive Warfarin?

2000 • 600 citations

Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1999 • 600 citations

Characterization of Different Subsets of Atrial Fibrillation in General Practice in France

1999 • 586 citations

Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome

2009 • 462 citations

Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation

2006 • 379 citations

Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation

2006 • 302 citations

Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control

2008 • 292 citations

Recent National Patterns of Warfarin Use in Atrial Fibrillation

1998 • 233 citations

Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk

2008 • 229 citations

Status of Antithrombotic Therapy for Patients With Atrial Fibrillation in University Hospitals

1996 • 160 citations

Patterns and Predictors of Warfarin Use in Patients With New-Onset Atrial Fibrillation from the FRACTAL Registry

2006 • 109 citations

Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation

2007 • 88 citations

Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdict

2008 • 70 citations

Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey

2007 • 39 citations

New oral anticoagulants: not quite there yet

2009 • 15 citations